EtQ Reliance
EtQ is the leading quality, compliance and EHS management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration.
EtQ is the leading quality, compliance and EHS management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration.
EtQ offers enterprise quality, compliance and EHS management solutions to a variety of industries. Moreover, EtQ offers visibility and control. Not only does its compliance platform, EtQ Reliance, provide companies with a wide variety of modules, it also provides them with the ability to control how they interact with unique business processes. At the core of EtQ’s framework is a flexible workflow tool that enables organizations to mimic their existing processes, create new ones and automate and control their compliance ecosystem. In addition to helping companies control the process, EtQ provides visibility into the compliance process. Through enterprise reporting, searching, and dashboards, companies can uncover adverse events, make better decisions and improve compliance at both the macro and micro level. Some of the processes that EtQ helps to automate include risk management, employee training, and audit management. EtQ was founded in 1992 and has main offices located in Europe and the U.S. EtQ has been providing software solutions to a variety of markets for more than 20 years. To learn more, visit www.etq.com or blog.etq.com.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Fast and Efficient Sialic Acid Clone Selection Using Lectin-Based High-Throughput Screening
June 2nd 2025Glycosylation is a common and critical post-translational modification that affects protein function and therapeutic efficacy, making its monitoring and accurate quantification essential for drug development.
